Common Contracts
2 similar Master Services Agreement contracts by Amryt Pharma PLC
FOURTH AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
This Fourth Amendment (the “Amendment”) to the Master Services Agreement dated December 6, 2013, as amended, by and between Aegerion Pharmaceuticals, Inc. (“Aegerion”), as assignee of AstraZeneca Pharmaceuticals LP, and Accredo Health Group, Inc. (“Service Provider”) (the “Agreement”) is effective as of October 19, 2017 (the “Amendment Effective Date”). Any capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Agreement.
FOURTH AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
This Fourth Amendment (the “Amendment”) to the Master Services Agreement dated December 6, 2013, as amended, by and between Aegerion Pharmaceuticals, Inc. (“Aegerion”), as assignee of AstraZeneca Pharmaceuticals LP, and Accredo Health Group, Inc. (“Service Provider”) (the “Agreement”) is effective as of October 19, 2017 (the “Amendment Effective Date”). Any capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Agreement.
